Matches in Wikidata for { <http://www.wikidata.org/entity/Q63600030> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q63600030 description "clinical trial" @default.
- Q63600030 description "ensayu clínicu" @default.
- Q63600030 description "klinisch onderzoek" @default.
- Q63600030 description "клінічне випробування" @default.
- Q63600030 description "կլինիկական փորձարկում" @default.
- Q63600030 name "A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting" @default.
- Q63600030 type Item @default.
- Q63600030 label "A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting" @default.
- Q63600030 prefLabel "A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting" @default.
- Q63600030 P1050 Q63600030-6EFBFDAB-FC9A-4095-B145-3E8B2ECFC3C0 @default.
- Q63600030 P1050 Q63600030-70D701EF-5DAA-4727-A4EC-641F0FE6454F @default.
- Q63600030 P1132 Q63600030-BDE3B75C-59A6-44D8-BCE6-F469A867D6B5 @default.
- Q63600030 P1476 Q63600030-659032C7-54C5-4533-A60C-6562E8D67DE5 @default.
- Q63600030 P17 Q63600030-8E78B75C-DB91-42EF-B8A0-69E4A23BE67F @default.
- Q63600030 P1813 Q63600030-01815AE9-8B34-4010-AF69-E3F161F7B8AC @default.
- Q63600030 P2899 Q63600030-9F9E771E-F5A4-4D37-A296-08390AA7E276 @default.
- Q63600030 P3098 Q63600030-096F28C0-0195-482D-8D8B-42E5867DEC73 @default.
- Q63600030 P31 Q63600030-D926EB5B-D809-416B-9B51-54190D1E649F @default.
- Q63600030 P4844 Q63600030-9E248F94-B33F-4C8B-A16A-4642472DD524 @default.
- Q63600030 P580 Q63600030-ED6F924D-D631-4436-9CAF-0B66CB9B244C @default.
- Q63600030 P582 Q63600030-0F23BDFD-852B-47E4-8FD5-9637B4437F2D @default.
- Q63600030 P6099 Q63600030-BCCBFA07-759A-49FC-803E-1456CD69F694 @default.
- Q63600030 P6153 Q63600030-02E1A657-B09C-4B65-AF88-A894239193FC @default.
- Q63600030 P8363 Q63600030-6B083BB8-4EF6-4685-BD01-71F962449B6C @default.
- Q63600030 P859 Q63600030-01392EC8-F2F8-4B30-B746-21157A3D1721 @default.
- Q63600030 P1050 Q140067 @default.
- Q63600030 P1050 Q8277 @default.
- Q63600030 P1132 "+570" @default.
- Q63600030 P1476 "An Open-Label, Single-Arm Phase IV Study To Assess Ocrelizumab Efficacy, Safety, And Impact On Patient Reported Outcomes (PROS) In Patients With Active Relapsing Multiple Sclerosis" @default.
- Q63600030 P17 Q142 @default.
- Q63600030 P1813 "PRO-MSACTIVE" @default.
- Q63600030 P2899 "+18" @default.
- Q63600030 P3098 "NCT03589105" @default.
- Q63600030 P31 Q30612 @default.
- Q63600030 P4844 Q2013780 @default.
- Q63600030 P580 "2018-08-06T00:00:00Z" @default.
- Q63600030 P582 "2020-08-17T00:00:00Z" @default.
- Q63600030 P6099 Q42825046 @default.
- Q63600030 P6153 Q30279962 @default.
- Q63600030 P8363 Q78089383 @default.
- Q63600030 P859 Q212646 @default.